127 (PB115): Survival benefit and tumor regression with a dual RAS/β-catenin inhibitor, ADT-030, in murine models of pancreatic and lung cancer by Bandi, D.S.R., Nagaraju, G.P., Foote, J.B., Keeton, A., Chen, X., Berry, K.L., Maxuitenko, Y.Y., Manne, U., Buchsbaum, D.J., Piazza, G.A., El-Rayes, B.F.

Get full text

133 (PB121): A novel pan-RAS inhibitor (ADT-1004) with superior efficacy over mutation-specific KRAS inhibitors in mouse models of pancreatic cancer by Bandi, D.S.R., Nagaraju, G.P., Foote, J.B., Keeton, A., Chen, X., Berry, K.L., Maxuitenko, Y.Y., Manne, U., Buchsbaum, D.J., Piazza, G.A., El-Rayes, B.F.

Get full text